1. Soldovieri, Maria Virginia, Ambrosino, Paolo, Mosca, Ilaria, Taglialatela, Maurizio, Lemke, Johannes R. 2023. De novo variants in KCNA3 cause developmental and epileptic encephalopathy. In Annals of neurology, 95, 365-376. doi:10.1002/ana.26826. https://pubmed.ncbi.nlm.nih.gov/37964487/
2. Ota, Masao, Ito, Tetsuya, Umemura, Takeji, Hamano, Hideaki, Kawa, Shigeyuki. . Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population. In Disease markers, 31, 223-9. doi:10.3233/DMA-2011-0820. https://pubmed.ncbi.nlm.nih.gov/22045429/
3. Quan, Qingli, Xiong, Xinxin, Wu, Shanyun, Yu, Meixing. 2021. Identification of Immune-Related Key Genes in Ovarian Cancer Based on WGCNA. In Frontiers in genetics, 12, 760225. doi:10.3389/fgene.2021.760225. https://pubmed.ncbi.nlm.nih.gov/34868239/
4. Hosseinzadeh, Zohreh, Warsi, Jamshed, Elvira, Bernat, Shumilina, Ekaterina, Lang, Florian. 2015. Up-regulation of Kv1.3 channels by janus kinase 2. In The Journal of membrane biology, 248, 309-17. doi:10.1007/s00232-015-9772-2. https://pubmed.ncbi.nlm.nih.gov/25644777/
5. Lioudyno, Victoria, Abdurasulova, Irina, Negoreeva, Irina, Klimenko, Victor, Lioudyno, Maria. 2020. A common genetic variant rs2821557 in KCNA3 is linked to the severity of multiple sclerosis. In Journal of neuroscience research, 99, 200-208. doi:10.1002/jnr.24596. https://pubmed.ncbi.nlm.nih.gov/32056271/
6. Zhong, Xiaolin, Lü, Muhan, Wan, Juyi, Zhou, Tiejun, Qin, Bo. 2018. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 107, 382-389. doi:10.1016/j.biopha.2018.07.118. https://pubmed.ncbi.nlm.nih.gov/30099342/